Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study (Q37125983)
Jump to navigation
Jump to search
scientific article published on 26 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study |
scientific article published on 26 July 2016 |
Statements
Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study (English)
Ole P Kristiansen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference